| J9271 | Injection, pembrolizumab, 1 mg | 11,200 | $40 | $481.6K |
| J0897 | Injection, denosumab, 1 mg | 5,940 | $20 | $106.9K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,230 | $30 | $76K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 300 | $90 | $26.7K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 25,500 | $1 | $25.5K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,490 | $10 | $20.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $100 | $15.2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 200 | $70 | $14.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 140 | $60 | $8.3K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 50 | $160 | $7.4K |